HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Autosomal Recessive 16 Deafness

Also Known As:

Deafness, Autosomal Recessive 16; DFNB16

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1.	Deafness (Deaf Mutism)
2.	Otosclerosis
3.	congenital stationary Night blindness

Experts

1.	Kaplan, Josseline: 1 article (01/2019)
2.	Marlin, Sandrine: 1 article (01/2019)
3.	Mechaussier, Sabrina: 1 article (01/2019)
4.	Perrault, Isabelle: 1 article (01/2019)
5.	Rozet, Jean-Michel: 1 article (01/2019)
6.	Blanchard, S: 1 article (11/2001)
7.	Del Castillo, I: 1 article (11/2001)
8.	Hutchin, T P: 1 article (11/2001)
9.	Lainé, S: 1 article (11/2001)
10.	Leibovici, M: 1 article (11/2001)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Autosomal Recessive 16 Deafness:

1.	Retinaldehyde (Retinal)IBA 01/01/2019 - "Consistent with the pure CSNB2A retinal involvement, SHL was ascribed to biallelic mutations in another gene, STRC, involved in nonprogressive DFNB16 deafness."
2.	Proteins (Proteins, Gene)FDA Link 11/01/2001 - "Mutations in a new gene encoding a protein of the hair bundle cause non-syndromic deafness at the DFNB16 locus."
3.	2-toluenesulfonamide (OTS)IBA 09/01/2001 - "This region does not overlap with DFNB16 locus but partially coincides with the otosclerosis (OTS) locus. "